Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · IEX Real-Time Price · USD
5.75
-0.03 (-0.52%)
At close: Jul 19, 2024, 12:00 AM
5.67
-0.08 (-1.39%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
BDTX Employees
Black Diamond Therapeutics had 54 employees as of December 31, 2023. The number of employees decreased by 11 or -16.92% compared to the previous year.
Employees
54
Change (1Y)
-11
Growth (1Y)
-16.92%
Revenue / Employee
n/a
Profits / Employee
-$1,477,630
Market Cap
323.45M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 54 | -11 | -16.92% |
Dec 31, 2022 | 65 | -21 | -24.42% |
Dec 31, 2021 | 86 | 17 | 24.64% |
Dec 31, 2020 | 69 | 37 | 115.63% |
Dec 31, 2019 | 32 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Zynex | 1,100 |
Spok Holdings | 384 |
Amarin Corporation | 275 |
Nautilus Biotechnology | 167 |
Foghorn Therapeutics | 116 |
Scilex Holding Company | 105 |
Solid Biosciences | 88 |
ALX Oncology Holdings | 72 |
BDTX News
- 7 weeks ago - Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 7 weeks ago - Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 3 months ago - Black Diamond Therapeutics Announces Changes to Board of Directors - GlobeNewsWire
- 3 months ago - Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting - GlobeNewsWire
- 3 months ago - Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire